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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S453change in CD59 mRNA levels was insigniﬁcant. While the abundance
of transcripts encoding MAC components and CD59 drop to insig-
niﬁcant values thereafter, expression of C3 remained signiﬁcantly
greater than control at days 5 and 9 (3.5 and 3.1-fold, p ¼ 8.05E-22
and 2.15E-05, respectively).
Conclusions: Most complement activators, MAC components and
inhibitors were signiﬁcantly upregulated in the synovium after ACL
transection. Although further characterization of the complement
activation in human knee joints after ACL injury is needed, the porcine
model may be a relevant preclinical model for the testing of therapeutic
candidates for blocking the complement response of the joint after
injury.
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HYDROSTATIC PRESSURE INDUCES INCREASED PRODUCTION OF
TGF-b VIA ERK ACTIVATION IN SYNOVIAL FIBROBLASTS FROM
RZAT TEMPOROMANDIBULAR JOINT
M. Wu y, Y. Yu y, Y. Zhou y, H. Lu z, Z. Gu z. yHosp. of Stomatology, Zhejiang
Univ., Hangzhou, China; z Sch. of Stomatology, Zhejiang Chinese Med.
Univ., Hangzhou, China
Purpose: TGF-b plays important roles in proliferation, differentiation,
and transition of ﬁbroblasts. The objective of present study was to
investigate whether the release of TGF-b was correlated to the magni-
tude of hydrostatic pressure (HP) in synovial ﬁbroblasts (SFs) from rattemporomandibular joint, and explore its potential relationship with
activation of MAP kinase pathway.
Methods: SFs isolated from double condyles of rat temporomandibular
joint were treated with hydrostatic pressures (HP) of 30, 60, and 90 kPa
HP for 12 hours. The production of transforming growth factor-beta
(TGF-b) in SFs suffered with different HP was determined by ELISA from
5 minutes to 12 hours in absence and presence of ERK1/2 inhibitor
(PD98059). Furthermore, the activation of ERK1, JNK and p38 MAPKs in
response to the treatment of hydrostatic pressure were examined by
Western blot.
Results: Compared with untreated control, the level of TGF-b dramat-
ically increased in synovial with hydrostatic pressure of 30 kPa from 5
minutes to 4 hours, while co-treatment of PD98059 can attenuate the
increase. The TGF-b production was slightly increased in synovial with
higher pressure (60 and 90 kPa), while PD98059 can also reduce the
increase. Hydrostatic pressure can signiﬁcantly up-regulated the
phosphorylation of ERK1/2 in SFs, whilst signiﬁcant activations of JNK
and p38 were not observed.
Conclusions: TGF-b is generally thought to play an important role in
bone development, remodeling and osteogenesis. According to our
ﬁndings, SFs treated with PD98059 caused a decrease in TGF-b pro-
duction stimulated by HP, indicating that the ERK1/2 pathway is
essential for the enhancement of TGF-b production induced by HP.
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SYNOVIAL EXPRESSION OF CCL19 AND ITS RECEPTOR CCR7 IN
PATIENTS WITH MENISCAL PATHOLOGY: VARIABILITY AND
RELATIONSHIP WITH KNEE SYMPTOMS
A. Nair y, J. Gan y, N. Verma y, C. Bush-Joseph y, M. Tetreault y, K.B. Rajan y,
L. Fogg y, C.R. Scanzello z. yRush Univ. Med. Ctr., Chicago, IL, USA; zUniv. of
Pennsylvania, Philadelphia, PA, USA
Purpose: Although patients with meniscal tears are at increased risk for
progressive OA, the relationship between meniscal pathology and knee
symptoms is not clear. In a previous pilot study, we demonstrated that
synovitis is associated with worse knee symptoms and dysfunction in
patients undergoing partial meniscectomy, mRNA expression levels of
the chemokine CCL19 and its receptor CCR7 were associated with
presence of synovitis, and also strongly correlated with knee symptoms.
But many patients indicated for meniscal arthroscopy already have
early-stage OA, unlike the patients included in the pilot who had nor-
mal knee radiographs. Therefore, we tested whether similar relation-
ships between CCL19, CCR7 and symptoms could be found in more
typical patients presenting for meniscal arthroscopy. In addition, we
sought to determine whether CCL19 and CCR7 protein expression in
synovial ﬂuid (SF) and synovial membrane (SM), respectively, varies
with symptomatic knee disease.
Methods: SF and SM specimens were collected during surgery from
patientsundergoingmeniscal arthroscopy. SMbiopsies formRNAanalysis
were available from 19 patients, and SF from 32 patients. SM mRNA for
CCL19 and CCR7 was measured using real-time PCR, and SF CCL19
measured by ELISA (R&D systems). The KOOS (Knee Injury and Osteo-
arthritis Outcome Score) was administered preoperatively, andmeasures
knee symptoms and dysfunction in 5 separate domains: pain, other
symptoms, activities of daily living (ADL), sport and recreation function,
and knee-related quality of life (QOL). Pearson’s correlationswere used to
determine relationships between mRNA or SF levels and KOOS scores.
Multivariable linear regression models were run to test if associations
were independent of age, gender, BMI, cartilage degeneration (measured
using Outerbridge Classiﬁcation) and radiographic OA (Kellgren-Law-
rence) scores. Synovial CCR7 expression was characterized using immu-
nohistochemical (IHC) staining, and compared to staining in SM from
advanced OA patients and asymptomatic post-mortem donors.
Results: The majority of meniscal patients had grade 2-4 Outerbridge
scores and median K/L scores of 2, indicative of pre-existing OA. CCL19
and CCR7 transcripts were detected in all patients. CCL19 relative
expression (RE) was associated with KOOS ADL (r ¼ -0.620, p ¼ 0.005),
Pain (r ¼ -0.547, p ¼ 0.015), and QOL scores (r ¼ -0.479, 0.038), and
multivariate models showed CCL19 RE was independently associated
only with KOOS ADL scores (b ¼ -4.201, 95% CI [-8.071, -0.331], p ¼
0.036). CCL19 protein was detectable in SF from 25/32 patients (78%),
and mean concentrationþ/-SD was 374.28þ/-367.58 pg/m. In unad-
justed correlations, SF CCL19 concentration was also associated with
worse KOOS-ADL subscores (Pearson r¼ -0.362, p¼ 0.049), but this was
not independent of other factors in adjusted regression analyses. IHC
